Technical Analysis for NURPF - Neuren Pharmaceutica

Grade Last Price % Change Price Change
grade A 1.71 10.32% 0.1600
NURPF closed up 10.32 percent on Friday, October 18, 2019, on 29 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NURPF trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Sell Signal Bearish 10.32%
Narrow Range Bar Range Contraction 10.32%
Upper Bollinger Band Walk Strength 10.32%

Older signals for NURPF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neuren Pharmaceuticals Limited, a biopharmaceutical company, engages in the development of therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its lead product is Trofinetide, which is in Phase II clinical trials for use in the treatment of Rett syndrome, Fragile X syndrome, moderate to severe traumatic brain injury, and concussion. The company is also developing NNZ-2591 that is in preclinical development for the treatment of various neurological disorders. In addition, it holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Auckland, New Zealand.
RTT Medical Specialties Biopharmaceutical Organ Systems Psychiatric Diagnosis Neurological Disorders Amyotrophic Lateral Sclerosis Neurotrauma Rett Syndrome Treatment Of Various Neurological Disorders Concussion Neurodegenerative Disorders
Is NURPF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 2.73
52 Week Low 0.0004
Average Volume 1,403
200-Day Moving Average 0.9126
50-Day Moving Average 0.9639
20-Day Moving Average 1.0517
10-Day Moving Average 1.25
Average True Range 0.0792
ADX 25.6
+DI 75.6164
-DI 20.7532
Chandelier Exit (Long, 3 ATRs ) 1.4724
Chandelier Exit (Short, 3 ATRs ) 0.9776
Upper Bollinger Band 1.5976
Lower Bollinger Band 0.5058
Percent B (%b) 1.1
BandWidth 103.812874
MACD Line 0.1457
MACD Signal Line 0.0558
MACD Histogram 0.0899
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.7100
Resistance 3 (R3) 1.7100 1.7100 1.7100
Resistance 2 (R2) 1.7100 1.7100 1.7100 1.7100
Resistance 1 (R1) 1.7100 1.7100 1.7100 1.7100 1.7100
Pivot Point 1.7100 1.7100 1.7100 1.7100 1.7100
Support 1 (S1) 1.7100 1.7100 1.7100 1.7100 1.7100
Support 2 (S2) 1.7100 1.7100 1.7100 1.7100
Support 3 (S3) 1.7100 1.7100 1.7100
Support 4 (S4) 1.7100